Veterinary Medicines

Biocan Novel R, Suspension for injection

Authorised
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
Download as PDF

Product identification

Medicine name:
Biocan Novel R, Suspension for injection
Biocan Novel R, süstesuspensioon koertele
Active substance:
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
    2.00
    international unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:
  • Glass Vial 10 x 10.0 Dose
  • Glass Vial 1 x 10.0 Dose
  • Glass Vial 50 x 1.0 Dose
  • Glass Vial 25 x 1.0 Dose
  • Glass Vial 10 x 1.0 Dose

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 2224
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0162/001
Concerned member states:
  • Bulgaria
  • Croatia
  • Estonia
  • Hungary
  • Latvia
  • Lithuania
  • Poland
  • Romania
  • Slovakia
  • Slovenia

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 2/01/2026
Download